GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Crinetics Pharmaceuticals Inc (STU:6Z4) » Definitions » Institutional Ownership

Crinetics Pharmaceuticals (STU:6Z4) Institutional Ownership : 73.37% (As of Apr. 29, 2025)


View and export this data going back to 2019. Start your Free Trial

What is Crinetics Pharmaceuticals Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Crinetics Pharmaceuticals's institutional ownership is 73.37%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Crinetics Pharmaceuticals's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Crinetics Pharmaceuticals's Float Percentage Of Total Shares Outstanding is 97.59%.


Crinetics Pharmaceuticals Institutional Ownership Historical Data

The historical data trend for Crinetics Pharmaceuticals's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Crinetics Pharmaceuticals Institutional Ownership Chart

Crinetics Pharmaceuticals Historical Data

The historical data trend for Crinetics Pharmaceuticals can be seen below:

2024-06-30 2024-07-31 2024-08-31 2024-09-30 2024-10-31 2024-11-30 2024-12-31 2025-01-31 2025-02-28 2025-03-31
Institutional Ownership 71.14 74.05 75.04 80.77 88.84 89.68 72.92 72.10 73.02 73.37

Crinetics Pharmaceuticals Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Crinetics Pharmaceuticals Business Description

Traded in Other Exchanges
Address
6055 Lusk Boulevard, San Diego, CA, USA, 92121
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.

Crinetics Pharmaceuticals Headlines

No Headlines